PPT-The Possible Future of Liquid Biopsy in Cancer Prevention
Author : scarlett | Published Date : 2024-01-03
National Cancer Institute Charting the Course of Liquid Biopsy in Precision Prevention and Treatment December 16 2021 Ernest Hawk MD MPH Vice President and Head
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "The Possible Future of Liquid Biopsy i..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
The Possible Future of Liquid Biopsy in Cancer Prevention: Transcript
National Cancer Institute Charting the Course of Liquid Biopsy in Precision Prevention and Treatment December 16 2021 Ernest Hawk MD MPH Vice President and Head Division of Cancer Prevention and Population Sciences. When cancer starts in the breast it is called breast cancer Except for skin cancer breast cancer is the most common cancer in American women Breast cancer screening mammogram is an Xray picture of the breast Mammograms are the best way to find breas Version 2012. Spirotome 8-10-14G. Trocar. Helix needle. Cutting cannula. Release element. . FIRST . Manual. V. acuum . & Macro. Biopsy System. . CE & FDA Approved for 13 different applications. Analysis. Charles . J Ryan, MD. Professor of Clinical . Medicine and Urology. Helen Diller Family Comprehensive Cancer Center. University of California, San Francisco. Biomarker Analysis in Prostate . with . initial and follow-up . biopsies.. Patients . with false negatives . are . managed in . the same manner as . those . with true negatives.. Biopsies don’t tell the whole story.. Each core . represents . Alon Z. Weizer, MD, MS. Associate Professor of Urology. Associate Chair, Surgical Services, . Department of Urology, University of Michigan. Disclosures. Summus (eConsult Platform): Advisory Board. Outline. Reliable, noninvasive methods of cancer detection. . Use of . biofluids. (blood, urine, sputum, saliva, etc.). Less trauma and generally less risk to patients, especially those who are not candidates for invasive biopsy. . July2017 Volume 2JEMI-PEARLS71Written in Blood Liquid Biopsies for Cervical Cancer ScreeningEvelyn LiuDepartment of Microbiology and Immunology University of British Columbia BACKGROUND INFORMATIO Associate Professor Elin . Gray. Melanoma . Research Group. School of Medical and Health Sciences. Edith Cowan University, Perth, Western Australia. Blood Biomarkers of Cancer. AutoAbs. Wan et al., Nature Reviews Cancer 2017. Asymptomatic pt. General concern. +/- . FHx. CHAPS / IPSS / failed venesection / ?informed / ?. E. uropean guidance. Symptomatic pts (LUTS, ED, vis haem; LBP/. wt. loss). PSA (prostate-specific antigen) is a serine protease enzyme produced by prostate epithelial cells (both normal and malignant).. Sean Khozin, MD, MPH. CEO, CancerLinQ. @. SeanKhozin. Disclosure: Executive Committee, Alliance for Artificial Intelligence in Healthcare . Significant improvements in cancer mortality rates. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021 CA Cancer J Clin. 2021;71(1):7-33 . The aim of this leaflet is to answer questions you may have about a sentinel lymph node (SLN) biopsy. The leaflet explains what the surgical procedure involves and the benefits and risks of having From CEA to Complexomics, and How to Get There. Mark A. Watson, MD, PhD. Assoc. Professor, Pathology and Immunology. Div. Of Laboratory and Genomic Medicine. Washington University School of Medicine. December 16, 2021. Outline. Health Economics and Decision Making. Clinical Utility of Liquid Biopsies. Development of a Preliminary Liquid Biopsy CEA. Q&A. Health Economics and Decision Making. Health Economics and Economic Modeling. December 15-16, 2021 . Johns Hopkins. MGH. MGH. Washington U. UCLA. Yale. Earlier Detection of Cancer Using Non-Plasma Based Liquid Biopsies. Nick Papadopoulos and Chetan Bettegowda. Johns Hopkins School of Medicine.
Download Document
Here is the link to download the presentation.
"The Possible Future of Liquid Biopsy in Cancer Prevention"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents